These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25403204)

  • 1. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.
    Yuan C; Rubinson DA; Qian ZR; Wu C; Kraft P; Bao Y; Ogino S; Ng K; Clancy TE; Swanson RS; Gorman MJ; Brais LK; Li T; Stampfer MJ; Hu FB; Giovannucci EL; Kulke MH; Fuchs CS; Wolpin BM
    J Clin Oncol; 2015 Jan; 33(1):29-35. PubMed ID: 25403204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Recently Diagnosed Diabetes and Long-term Diabetes With Survival in Pancreatic Cancer Patients: A Pooled Analysis.
    Jeon CY; Li D; Cleary S; Stolzenberg-Solomon R; Bosetti C; La Vecchia C; Porta M; Toriola AT; Hung RJ; Kurtz RC; Olson SH
    Pancreas; 2018 Mar; 47(3):314-320. PubMed ID: 29401167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body mass index does not affect the survival of pancreatic cancer patients.
    Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
    World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Protective Effects of Diabetes Mellitus on Post-EVAR AAA Growth and Reinterventions.
    Png CYM; Tadros RO; Kang M; Beckerman WE; Tardiff ML; Vouyouka AG; Marin ML; Faries PL
    Ann Vasc Surg; 2017 Aug; 43():65-72. PubMed ID: 28302476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus and pancreatic cancer mortality in a prospective cohort of United States adults.
    Calle EE; Murphy TK; Rodriguez C; Thun MJ; Heath CW
    Cancer Causes Control; 1998 Aug; 9(4):403-10. PubMed ID: 9794172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New-onset diabetes and pancreatic cancer.
    Gupta S; Vittinghoff E; Bertenthal D; Corley D; Shen H; Walter LC; McQuaid K
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1366-72; quiz 1301. PubMed ID: 16945591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Impact of Diabetes Mellitus on Overall Survival in a Nationwide Population-Based Cohort of Patients With Pancreatic Cancer.
    Tseng CM; Wang HH; Wang WL; Lee CT; Tai CM; Tseng CH; Chen CC; Tsai YN; Sun MS; Hsu YC
    Endocr Pract; 2020 Jul; 26(7):707-713. PubMed ID: 33471638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin use and pancreatic cancer risk in two prospective cohort studies.
    Hamada T; Khalaf N; Yuan C; Babic A; Morales-Oyarvide V; Qian ZR; Nowak JA; Ng K; Kraft P; Rubinson DA; Stampfer MJ; Giovannucci EL; Fuchs CS; Ogino S; Wolpin BM
    J Gastroenterol; 2018 Aug; 53(8):959-966. PubMed ID: 29362938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan.
    Liao KF; Lai SW; Li CI; Chen WC
    J Gastroenterol Hepatol; 2012 Apr; 27(4):709-13. PubMed ID: 21929650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cigarette Smoking and Pancreatic Cancer Survival.
    Yuan C; Morales-Oyarvide V; Babic A; Clish CB; Kraft P; Bao Y; Qian ZR; Rubinson DA; Ng K; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Sesso HD; Cochrane BB; Manson JE; Fuchs CS; Wolpin BM
    J Clin Oncol; 2017 Jun; 35(16):1822-1828. PubMed ID: 28358654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Metabolites and Survival Among Patients With Pancreatic Cancer.
    Yuan C; Clish CB; Wu C; Mayers JR; Kraft P; Townsend MK; Zhang M; Tworoger SS; Bao Y; Qian ZR; Rubinson DA; Ng K; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Ma J; Sesso HD; Anderson GL; Cochrane BB; Manson JE; Torrence ME; Kimmelman AC; Amundadottir LT; Vander Heiden MG; Fuchs CS; Wolpin BM
    J Natl Cancer Inst; 2016 Jun; 108(6):djv409. PubMed ID: 26755275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes and pancreatic cancer survival: a prospective cohort-based study.
    Toriola AT; Stolzenberg-Solomon R; Dalidowitz L; Linehan D; Colditz G
    Br J Cancer; 2014 Jul; 111(1):181-5. PubMed ID: 24786605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes, Weight Change, and Pancreatic Cancer Risk.
    Yuan C; Babic A; Khalaf N; Nowak JA; Brais LK; Rubinson DA; Ng K; Aguirre AJ; Pandharipande PV; Fuchs CS; Giovannucci EL; Stampfer MJ; Rosenthal MH; Sander C; Kraft P; Wolpin BM
    JAMA Oncol; 2020 Oct; 6(10):e202948. PubMed ID: 32789511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
    Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
    JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergies, obesity, other risk factors and survival from pancreatic cancer.
    Olson SH; Chou JF; Ludwig E; O'Reilly E; Allen PJ; Jarnagin WR; Bayuga S; Simon J; Gonen M; Reisacher WR; Kurtz RC
    Int J Cancer; 2010 Nov; 127(10):2412-9. PubMed ID: 20143395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index, physical activity and the risk of pancreatic cancer in relation to smoking status and history of diabetes: a large-scale population-based cohort study in Japan--the JPHC study.
    Luo J; Iwasaki M; Inoue M; Sasazuki S; Otani T; Ye W; Tsugane S;
    Cancer Causes Control; 2007 Aug; 18(6):603-12. PubMed ID: 17401636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.
    Hamada T; Khalaf N; Yuan C; Morales-Oyarvide V; Babic A; Nowak JA; Qian ZR; Ng K; Rubinson DA; Kraft P; Giovannucci EL; Stampfer MJ; Fuchs CS; Ogino S; Wolpin BM
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1300-1306.e3. PubMed ID: 29474971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer.
    Bagni K; Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Hansen CP; Preus Hasselby J; Holländer NH; Nissen M; Bjerregaard JK; Pfeiffer P; Yilmaz MK; Rasmussen LS; Nielsen SE; Johansen JS
    Eur J Cancer Care (Engl); 2020 May; 29(3):e13219. PubMed ID: 31908093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.
    Simon TG; King LY; Chong DQ; Nguyen LH; Ma Y; VoPham T; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Khalili H; Chung RT; Zhang X; Chan AT
    Hepatology; 2018 May; 67(5):1797-1806. PubMed ID: 29152763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporality of clinical factors associated with pancreatic cancer: a case-control study using linked electronic health records.
    Dayem Ullah AZM; Stasinos K; Chelala C; Kocher HM
    BMC Cancer; 2021 Nov; 21(1):1279. PubMed ID: 34837975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.